DE60238765D1 - Carbamatverbindungen zur behandlung von schmerz - Google Patents

Carbamatverbindungen zur behandlung von schmerz

Info

Publication number: DE60238765D1
Authority: DE; Germany
Prior art keywords: pain; treatment; carbamate compounds; carbamate; compounds
Prior art date: 2001-02-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60238765T

Other languages

English (en)

Inventor

Carlos Plata-Salaman

Boyu Zhao

Roy Twyman

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Janssen Pharmaceuticals Inc

Original Assignee

Ortho McNeil Pharmaceutical Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-27

Filing date

2002-02-21

Publication date

2011-02-10

2002-02-21 Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc

2011-02-10 Application granted granted Critical

2011-02-10 Publication of DE60238765D1 publication Critical patent/DE60238765D1/de

2022-02-22 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

150000004657 carbamic acid derivatives Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

DE60238765T 2001-02-27 2002-02-21 Carbamatverbindungen zur behandlung von schmerz Expired - Lifetime DE60238765D1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US27188801P	2001-02-27	2001-02-27
PCT/US2002/005421 WO2002067922A1 (en)	2001-02-27	2002-02-21	Carbamate compounds for use in the treatment of pain

Publications (1)

Publication Number	Publication Date
DE60238765D1 true DE60238765D1 (de)	2011-02-10

Family

ID=23037511

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60238765T Expired - Lifetime DE60238765D1 (de)	2001-02-27	2002-02-21	Carbamatverbindungen zur behandlung von schmerz

Country Status (28)

Country	Link
US (1)	US6815464B2 (de)
EP (1)	EP1404312B1 (de)
JP (1)	JP4276838B2 (de)
KR (1)	KR100906315B1 (de)
CN (1)	CN1849116A (de)
AR (1)	AR033427A1 (de)
AT (1)	ATE493125T1 (de)
AU (1)	AU2002254015B2 (de)
BR (1)	BR0207673A (de)
CA (1)	CA2439274C (de)
CY (1)	CY1111349T1 (de)
CZ (1)	CZ20032298A3 (de)
DE (1)	DE60238765D1 (de)
DK (1)	DK1404312T3 (de)
ES (1)	ES2356617T3 (de)
HU (1)	HUP0303236A3 (de)
IL (1)	IL157593A0 (de)
MX (1)	MXPA03007721A (de)
MY (1)	MY129312A (de)
NO (1)	NO20033804L (de)
NZ (1)	NZ527994A (de)
PL (1)	PL364647A1 (de)
PT (1)	PT1404312E (de)
RS (1)	RS67603A (de)
RU (1)	RU2283106C2 (de)
TW (1)	TWI304735B (de)
WO (1)	WO2002067922A1 (de)
ZA (1)	ZA200307475B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2454049A1 (en) *	2001-07-16	2003-01-30	Ortho-Mcneil Pharmaceutical, Inc.	Carbamate compounds for use in preventing or treating neuropathic pain
WO2007112000A2 (en) *	2006-03-24	2007-10-04	Wyeth	Treatment of pain
US20100160351A1 (en) *	2008-12-19	2010-06-24	Nuon Therapeutics, Inc.	Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2010071865A1 (en)	2008-12-19	2010-06-24	Nuon Therapeutics, Inc.	Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2011032175A1 (en)	2009-09-14	2011-03-17	Nuon Therapeutics, Inc.	Combination formulations of tranilast and allopurinol and methods related thereto
JP5836280B2 (ja)	2009-11-06	2015-12-24	エスケーバイオファーマスティカルズカンパニーリミテッド	注意欠陥／多動性障害（ａｄｈｄ）の治療方法
JP5901528B2 (ja) *	2009-11-06	2016-04-13	エスケーバイオファーマスティカルズカンパニーリミテッド	線維筋痛症候群の治療方法
US8623913B2 (en)	2010-06-30	2014-01-07	Sk Biopharmaceuticals Co., Ltd.	Methods for treating restless legs syndrome
US9610274B2 (en)	2010-06-30	2017-04-04	Sk Biopharmaceuticals Co., Ltd.	Methods for treating bipolar disorder
US9018253B2 (en)	2010-07-02	2015-04-28	Bio-Pharm Solutions Co., Ltd.	Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en)	2010-11-30	2013-12-17	Fox Chase Chemical Diversity Center, Inc.	Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN102266317A (zh) *	2011-06-24	2011-12-07	中国人民解放军第三军医大学	丙戊酸及其衍生物的应用
CN104136413B (zh) *	2011-12-27	2016-10-26	比皮艾思药物研发有限公司	用于预防或治疗癫痫症的苯基氨基甲酸酯化合物
EP2968210A4 (de)	2013-03-12	2016-12-28	Bio-Pharm Solutions Co Ltd	Phenylcarbamatverbindungen zur verwendung in der vorbeugung oder behandlung pädiatrischer epilepsie und epilepsie-vermittelter syndrome
KR102421013B1 (ko) *	2016-05-19	2022-07-14	에스케이바이오팜 주식회사	삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3278380A (en)	1962-02-06	1966-10-11	Armour Pharma	Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en)	1962-07-18	1966-08-09	Armour Pharma	Substituted phenethyl carbamates
US5698588A (en)	1996-01-16	1997-12-16	Yukong Limited	Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
GB2340074A (en) *	1998-08-01	2000-02-16	Max Imaging Systems Limited	Printing process
CA2416819C (en)	2000-07-21	2011-03-22	Ortho-Mcneil Pharmaceutical, Inc.	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

2002
- 2002-02-21 PL PL02364647A patent/PL364647A1/xx unknown
- 2002-02-21 DK DK02723222.2T patent/DK1404312T3/da active
- 2002-02-21 AU AU2002254015A patent/AU2002254015B2/en not_active Ceased
- 2002-02-21 HU HU0303236A patent/HUP0303236A3/hu unknown
- 2002-02-21 JP JP2002567289A patent/JP4276838B2/ja not_active Expired - Fee Related
- 2002-02-21 BR BR0207673-0A patent/BR0207673A/pt not_active Application Discontinuation
- 2002-02-21 EP EP02723222A patent/EP1404312B1/de not_active Expired - Lifetime
- 2002-02-21 CA CA2439274A patent/CA2439274C/en not_active Expired - Fee Related
- 2002-02-21 MX MXPA03007721A patent/MXPA03007721A/es active IP Right Grant
- 2002-02-21 RS YUP-676/03A patent/RS67603A/sr unknown
- 2002-02-21 RU RU2003128984/14A patent/RU2283106C2/ru not_active IP Right Cessation
- 2002-02-21 ES ES02723222T patent/ES2356617T3/es not_active Expired - Lifetime
- 2002-02-21 WO PCT/US2002/005421 patent/WO2002067922A1/en active IP Right Grant
- 2002-02-21 IL IL15759302A patent/IL157593A0/xx unknown
- 2002-02-21 CZ CZ20032298A patent/CZ20032298A3/cs unknown
- 2002-02-21 KR KR1020037011260A patent/KR100906315B1/ko not_active IP Right Cessation
- 2002-02-21 AT AT02723222T patent/ATE493125T1/de active
- 2002-02-21 DE DE60238765T patent/DE60238765D1/de not_active Expired - Lifetime
- 2002-02-21 NZ NZ527994A patent/NZ527994A/en unknown
- 2002-02-21 CN CNA028089227A patent/CN1849116A/zh active Pending
- 2002-02-21 PT PT02723222T patent/PT1404312E/pt unknown
- 2002-02-21 US US10/081,943 patent/US6815464B2/en not_active Expired - Fee Related
- 2002-02-27 AR ARP020100699A patent/AR033427A1/es unknown
- 2002-02-27 TW TW091103502A patent/TWI304735B/zh not_active IP Right Cessation
- 2002-02-27 MY MYPI20020695A patent/MY129312A/en unknown
2003
- 2003-08-26 NO NO20033804A patent/NO20033804L/no not_active Application Discontinuation
- 2003-09-25 ZA ZA200307475A patent/ZA200307475B/xx unknown
2011
- 2011-03-22 CY CY20111100309T patent/CY1111349T1/el unknown

Also Published As

Publication number	Publication date
JP2004523553A (ja)	2004-08-05
JP4276838B2 (ja)	2009-06-10
ZA200307475B (en)	2005-01-03
CY1111349T1 (el)	2015-08-05
ATE493125T1 (de)	2011-01-15
RU2003128984A (ru)	2005-03-20
HUP0303236A3 (en)	2012-07-30
EP1404312B1 (de)	2010-12-29
MY129312A (en)	2007-03-30
IL157593A0 (en)	2004-03-28
PL364647A1 (en)	2004-12-13
TWI304735B (en)	2009-01-01
NO20033804L (no)	2003-09-30
NO20033804D0 (no)	2003-08-26
PT1404312E (pt)	2011-02-01
CA2439274A1 (en)	2002-09-06
DK1404312T3 (da)	2011-03-14
NZ527994A (en)	2005-11-25
MXPA03007721A (es)	2004-11-12
CA2439274C (en)	2011-04-05
CN1849116A (zh)	2006-10-18
US20020156127A1 (en)	2002-10-24
US6815464B2 (en)	2004-11-09
BR0207673A (pt)	2004-12-28
EP1404312A1 (de)	2004-04-07
HUP0303236A2 (hu)	2004-01-28
AU2002254015B2 (en)	2006-08-24
RS67603A (en)	2007-02-05
ES2356617T3 (es)	2011-04-11
KR100906315B1 (ko)	2009-07-07
WO2002067922A1 (en)	2002-09-06
AR033427A1 (es)	2003-12-17
KR20030076711A (ko)	2003-09-26
RU2283106C2 (ru)	2006-09-10
CZ20032298A3 (cs)	2004-08-18

Publication	Publication Date	Title
DE50009504D1 (de)	2005-03-17	Verwendung von retigabin zur behandlung von neuropathischen schmerzen
DE60124302D1 (de)	2006-12-14	Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE512163T1 (de)	2011-06-15	Verabreichung von mitteln zur behandlung von entzündungen
DE50206657D1 (de)	2006-06-08	Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
ATE410430T1 (de)	2008-10-15	2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
ATE417602T1 (de)	2009-01-15	Mittel zur behandlung von erkrankungen der speiseröhre
ATE413385T1 (de)	2008-11-15	Zur behandlung von schmerzen geeignete therapeutische mittel
DE60136477D1 (de)	2008-12-18	Retinoide zur behandlung von emphysem
DE60208221D1 (de)	2006-01-26	Heterozyklische verbindungen zur behandlung von harnwegserkrankungen
ATE414512T1 (de)	2008-12-15	Kombinationstherapie zur behandlung von krebs
DE60204466D1 (de)	2005-07-07	Integrinhemmer zur behandlung von augenkrankheiten
DE502004010131D1 (de)	2009-11-05	Pyridopyrimidinone zur behandlung von krebserkrankungen
DE60238765D1 (de)	2011-02-10	Carbamatverbindungen zur behandlung von schmerz
DE60221670D1 (de)	2007-09-20	Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen
DE60236743D1 (de)	2010-07-29	Zur behandlung androgenabhängiger krankheiten
DE50013843D1 (de)	2007-01-18	Arzneimittel zur behandlung von darmerkrankungen
DE602004019576D1 (de)	2009-04-02	Zur behandlung von schmerzen geeignete piperazine
DE60214355D1 (de)	2006-10-12	Exemestan zur behandlung von hormonabhängigen störungen
DE50105735D1 (de)	2005-04-28	Chlorzoxazon zur behandlung von psoriasis
ATE312104T1 (de)	2005-12-15	Verbindungen zur behandlung von beeinträchtigten fundischen entspannung
ATE273276T1 (de)	2004-08-15	Cyclobutendion-derivate zur behandlung von artherosclerose
DE60216457D1 (de)	2007-01-11	Carbamate verbindungen zur behandlung oder verhutung von psychotischen krankheiten
DE60223707D1 (de)	2008-01-03	Calcium-l-threonat zur behandlung von knochenfrakturen
DE60021252D1 (de)	2005-08-18	Antikonvulsiva zur behandlung von autismus
DE60103685D1 (de)	2004-07-15	Behandlung von Poriomania